advertisement
11.3.4 Betablocker (14)
Showing records 1 to 14
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker8483 Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability
Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
Ophthalmology 2003; 110: 615-624
8585 Influence of topical betaxolol and timolol on visual field in Japanese open-angle glaucoma patients
Araie M; Azuma I; Kitazawa Y
Japanese Journal of Ophthalmology 2003; 47: 199-207
8487 Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension
Day DG; Schacknow PN; Wand M; Sharpe ED; Stewart JA; Leech JN; Stewart WC
American Journal of Ophthalmology 2003; 135: 138-143
8488 Protective effects of timolol against the neuronal damage induced by glutamate and ischemia in the rat retina
Goto W; Ota T; Morikawa N; Otori Y; Hara H; Kawazu K; Miyawaki N; Tano Y
Brain Research 2002; 958: 10-19
8688 Results of the betaxolol versus placebo treatment trial in ocular hypertension
Kamal D; Garway-Heath DF; Ruben S; O'Sullivan F; Bunce C; Viswanathan A; Franks W; Hitchings RA
Graefe's Archive for Clinical and Experimental Ophthalmology 2003; 241: 196-203
8712 The efficacy and safety of the timolol/dorzolamide fixed combination versus latanoprost in exfoliation glaucoma
Konstas AGP; Kozobolis VP; Tersis I; Leech JN; Stewart WC
Eye 2003; 17: 41-46
8852 The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol
Wood JPM; Schmidt KG; Melena J; Chidlow Gallmeier H; Osborne NN
Experimental Eye Research 2003; 76: 505-516
8660 Hypotensive effect of timolol and latanoprost instillation in normal-tension glaucoma
Hashimoto T; Hara T; Takahashi Y; Kubota S; Kubota M; Tsuru T
Japanese Journal of Clinical Ophthalmology 2003; 57: 288-291
8774 The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension
Orzalesi N; Rossetti L; Bottoli A; Fumagalli E; Fogagnolo P
Archives of Ophthalmology 2003; 121: 453-457
8776 Comparison of the intraocular pressure lowering effect of latanoprost and carteolol-pilocarpine combination in newly diagnosed glaucoma
Ozdemir M; Ozdemirm G
Japanese Journal of Ophthalmology 2003; 47: 72-76
8812 A prospective, long-term, randomized study of the efficacy and safety of the drug combination pilocarpine 1% with clonidine 0.06% or clonidine 0.125% versus timolol 0.25%
Sihota R; Rajashekhar YL; Venkatesh P; Agarwal H
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 499-506
8715 Comparative efficacy of gel-forming and ophthalmic solutions of 0.5% timolol in open-angle glaucoma
Kumar S; Pannu BKS; Sawhney R; Jain R; Sood S
Annals of ophthalmology (Skokie, Ill.) 2002; 34: 211-214
8810 Comparison of efficacy and tolerability between two gel-forming timolol maleate ophthalmic solutions in patients with glaucoma or ocular hypertension
Shibuya T; Kashiwagi K; Tsukahara S
Ophthalmologica 2003; 217: 31-38
8829 Efficacy and safety of long-acting carteolol 1% once daily: a double-masked, randomized study
Trinquand C; Romanet JP; Nordmann JP; Allaire C
Journal Français d'Ophtalmologie 2003; 26: 131-136